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Abstract 
Abstract 
A novel CUX1-NUTM1 fusion identified in B-cell 
precursor acute lymphoblastic leukemia. 
Keywords 
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Clinics and pathology 
Disease 
B-cell precursor acute lymphoblastic leukemia 
(BCP-ALL) 
Phenotype/cell stem origin 
Pro-B immunophenotype (B-I EGIL cIassification): 
CD19+, CD22+, CD79a+, partial CD20+, CD10-, 
cμ- and aberrant expression of CD33. 
Epidemiology 
Only one case described, a 15-year-old female. 
der(7)t(7;15)(q22;q14), R-band analysis. 
Cytogenetics 
Cytogenetics morphological 
Unbalanced t(7;15)  
der(7)t(7;15)(q22;q14)dup(7)(q11q22)del(7)(p11) 
Additional anomalies 
There was no additional anomaly. 
der(7)t(7;15)(q22;q14)dup(7)(q11q22)del(7)(p11); probes: 
wcp7 green, wcp15 red. 
Genes involved and 
proteins 
Note 
Fusion CUX1-NUTM1 
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der(7)t(7;15)(q22;q14)dup(7)(q11q22)del(7)(p11). 
CUX1 (cut-like homeobox 1) 
Location 
7q22.1 
DNA/RNA 
CUX1 locus spans approximately 468 kb and 
contains 24 exons. 
CUX1 has been reported as a haploinsufficient 
tumor suppressor gene on chromosome 7 frequently 
inactivated in acute myeloid leukemia (McNerney, 
2013). It has also been involved in a gene fusion with 
FGFR1 (Wasag, 2011). 
Protein 
CUX1 is a 164 kDa nuclear protein. This protein is a 
member of the homeodomain family of DNA 
binding proteins. It may regulate gene expression,  
morphogenesis, and differentiation and it may also 
play a role in the cell cycle progression (Ramdzan 
ZM, 2014). Several different isoforms encoded by 
alternatively spliced transcript variants have been 
identified. [provided by RefSeq, Feb 2011]. 
NUTM1 (nuclear protein in testis) 
Location 
15q14 
DNA/RNA 
NUTM1 locus spans approximately 14 kb and 
contains 7 exons. 
Protein 
NUTM1 is a 120 kDa nuclear and cytoplasmic 
protein. Its function is still unknown. 
Result of the chromosomal 
anomaly 
Hybrid gene 
Note 
CUX1/NUTM1 
Description 
CUX1 exon 20 is fused in frame with NUTM1 exon 
5. 
Transcript 
The CUX1-NUTM1 fusion transcript was amplified. 
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